Literature DB >> 20061843

What are the fluid requirements in toxic epidermal necrolysis?

Sarah Shiga1, Rob Cartotto.   

Abstract

Acute fluid requirements in toxic epidermal necrolysis (TEN) have neither been quantified nor reported. The purpose of this study was to examine acute fluid administration in TEN patients. A consecutive series of criteria and biopsy-confirmed cases of TEN admitted to our burn centre were selected for retrospective analysis. Charts were reviewed for demographic and resuscitation variables for the first (D0), second (D1), and third (D2) 24-hour periods after burn center admission. Twenty-one TEN cases were available for study, with a mean epidermal detachment of 53 +/- 24% TBSA. Mortality was 29%, with all deaths occurring after the study period. Average crystalloid volumes decreased from D0 (2.2 +/- 1.5 ml/kg/%TBSA) through D1 (1.6 +/- 1.1 ml/kg/%TBSA) and D2 (1.4 +/- 1.0 ml/kg/%TBSA), whereas urine output increased from D0 (1.3 +/- 0.9 ml/kg/hr) through D1 (1.4 +/- 0.9 ml/kg/hr) and D2 (1.8 +/- 1.1 ml/kg/hr). Worst base deficit (BD) corrected significantly from D0 to D1 (P = .01) and from D1 to D2 (P = .002). There was no correlation between daily crystalloid volumes and %TBSA detachment. Nonsurvivors had significantly higher severity-of-illness score for TEN and 24-hour mean and worst BDs than survivors, but did not require significantly more crystalloid or display lower urine outputs. Initial provision of approximately 2 ml/kg/%TBSA epidermal detachment to patients with TEN resulted in more than adequate urine output and significant correction of the BD. We emphasize that these data do not represent a resuscitation formula but rather a guideline for initial fluid administration, which should then be titrated to the patient's response.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20061843     DOI: 10.1097/BCR.0b013e3181cb8cb8

Source DB:  PubMed          Journal:  J Burn Care Res        ISSN: 1559-047X            Impact factor:   1.845


  10 in total

Review 1.  Management of Drug-Induced Epidermal Necrolysis (DEN) in Pediatric Patients: Moving from Drug-Induced Stevens-Johnson Syndrome, Overlap and Toxic Epidermal Necrolysis to a Single Unifying Diagnosis of DEN.

Authors:  Michele L Ramien; Danny Mansour; Neil H Shear
Journal:  Paediatr Drugs       Date:  2022-06-09       Impact factor: 3.022

Review 2.  Cutaneous drug reactions in children: an update.

Authors:  Kara Heelan; Neil H Shear
Journal:  Paediatr Drugs       Date:  2013-12       Impact factor: 3.022

Review 3.  Bullous Drug Reactions.

Authors:  Maja Mockenhaupt
Journal:  Acta Derm Venereol       Date:  2020-02-12       Impact factor: 3.875

Review 4.  Drug induced exfoliative dermatitis: state of the art.

Authors:  Mona-Rita Yacoub; Alvise Berti; Corrado Campochiaro; Enrico Tombetti; Giuseppe Alvise Ramirez; Andrea Nico; Elisabetta Di Leo; Paola Fantini; Maria Grazia Sabbadini; Eustachio Nettis; Giselda Colombo
Journal:  Clin Mol Allergy       Date:  2016-08-22

Review 5.  Recent advances in managing and understanding Stevens-Johnson syndrome and toxic epidermal necrolysis.

Authors:  Akito Hasegawa; Riichiro Abe
Journal:  F1000Res       Date:  2020-06-16

6.  The influence of acute kidney injury on the outcome of Stevens-Johnson syndrome and toxic epidermal necrolysis: The prognostic value of KDIGO staging.

Authors:  Tao Han Lee; Cheng-Chia Lee; Chau-Yee Ng; Ming-Yang Chang; Su-Wei Chang; Pei-Chun Fan; Wen-Hung Chung; Ya-Chung Tian; Yung-Chang Chen; Chih-Hsiang Chang
Journal:  PLoS One       Date:  2018-09-07       Impact factor: 3.240

Review 7.  A contemporary snippet on clinical presentation and management of toxic epidermal necrolysis.

Authors:  Piyu Parth Naik
Journal:  Scars Burn Heal       Date:  2022-09-13

8.  A 7-year-old boy with toxic epidermal necrolysis, heart failure, and sepsis treated with the guidance of invasive hemodynamic monitoring: A case report.

Authors:  Amir Saeed; Nima Mehdizadegan
Journal:  Clin Case Rep       Date:  2021-07-06

Review 9.  Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Concise Review with a Comprehensive Summary of Therapeutic Interventions Emphasizing Supportive Measures.

Authors:  Jeremy A Schneider; Philip R Cohen
Journal:  Adv Ther       Date:  2017-04-24       Impact factor: 3.845

10.  Intravenous Immunoglobulin Combined With Corticosteroids for the Treatment of Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis: A Propensity-Matched Retrospective Study in China.

Authors:  Lu Yang; Yan-Hong Shou; Feng Li; Xiao-Hua Zhu; Yong-Sheng Yang; Jin-Hua Xu
Journal:  Front Pharmacol       Date:  2022-01-18       Impact factor: 5.810

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.